Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 05-2005 | 05-2004 | 05-2003 | 05-2002 | 05-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22 | -299 | -224 | -567 | -516 |
| Depreciation Amortization | 159 | 144 | 117 | 192 | 208 |
| Accounts receivable | -201 | 94 | -238 | 10 | 176 |
| Other Working Capital | 113 | -83 | 378 | -75 | 108 |
| Other Operating Activity | 23 | 69 | 480 | 309 | 190 |
| Operating Cash Flow | $73 | $-75 | $513 | $-131 | $166 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9 | 46 | N/A | 39 | 86 |
| PPE Investments | -242 | -436 | -232 | -12 | -62 |
| Net Acquisitions | N/A | N/A | N/A | 213 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -8 | -20 | -20 |
| Other Investing Activity | 0 | 0 | -8 | -20 | -23 |
| Investing Cash Flow | $-233 | $-390 | $-239 | $220 | $1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 175 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 95 |
| Debt Repayment | -16 | 4 | -62 | 280 | N/A |
| Common Stock Issued | 1 | 323 | 40 | 11 | 249 |
| Other Financing Activity | 0 | -33 | -53 | -63 | -4 |
| Financing Cash Flow | $160 | $293 | $-75 | $229 | $340 |
| Beginning Cash Position | 352 | 525 | 329 | 127 | 613 |
| End Cash Position | 352 | 352 | 525 | 329 | 127 |
| Net Cash Flow | $-1 | $-173 | $196 | $202 | $-486 |
| Free Cash Flow | |||||
| Operating Cash Flow | 73 | -75 | 513 | -131 | 166 |
| Capital Expenditure | -242 | -436 | -232 | -12 | -62 |
| Free Cash Flow | -169 | -511 | 281 | -143 | 104 |